Precede Foundation

Home
Precede Foundation

Hope, Accelerated

15/05/2026

UVACCC has joined PRECEDE! We are proud to partner with the UVA Health initiative to continue to transform pancreatic cancer outcomes—aiming to increase five-year survival rates from just 12.8% to 50%.

Because pancreatic cancer is often hard to detect early, data-sharing is the key to a breakthrough. UVA Health is already making a major impact with 170 patients enrolled in PRECEDE via their High-Risk Pancreatic Screening Clinic. Launched in 2013 by Clinic Director and Chief of Surgical Oncology, Dr. Todd Bauer, alongside Kathleen Haden, RN, MSN, ANP-C, this program was a national pioneer and the very first in Virginia dedicated to individuals with significant risk factors.

We are honored to support the clinicians and researchers at the UVA Comprehensive Cancer Center in our shared mission to change the future of pancreatic cancer detection. Let's get to work!💜

01/05/2026

This May, in recognition of National Cancer Research Month, we’re highlighting why continued research, early detection, and innovation are critical in the fight against pancreatic cancer. True progress happens when people pay attention and take action.

From groundbreaking advancements in mRNA technology to the power of global collaboration, there’s real momentum, but there’s still more to be done.

Read our latest blog to learn how PRECEDE is working to change the future of cancer detection and how you can be part of the progress.💜

17/04/2026

In a recent feature with HealthyWomen, Dr. Diane Simeone shares critical insights on early warning signs, risk factors, and why earlier detection is key to improving outcomes.

From subtle symptoms to the role of genetics and research, this conversation highlights what patients and providers need to know.

🔗 Read the full blog to learn more: [https://precedefoundation.org/dr-diane-simeone…healthywomen-org/]

16/04/2026

Early detection is critical to improving pancreatic cancer outcomes, and strong leadership helps drive that progress.

The PRECEDE Foundation has appointed Dr. Bryson Katona and Dr. Raymond Wadlow to its Executive Committee, strengthening its global efforts to identify high-risk individuals and advance early detection.

🔗 Read the full press release here: [https://precedefoundation.org/precede-foundation-appoints-bryson-katona-and-raymond-wadlow-to-its-executive-committee/]

10/04/2026

The latest National Comprehensive Cancer Network (NCCN) guidelines mark a major shift toward precision medicine—highlighting the importance of comprehensive molecular profiling, including NGS and RNA sequencing, to help personalize treatment for pancreatic cancer.

This update means more patients may gain access to targeted therapies, clinical trials, and care plans tailored to their unique biology—opening doors that were once out of reach. Our Founder and Chief Scientific Advisor, Dr. Diane Simeone, is a member of the NCCN Board and is closely connected to the organization guiding these advancements.

🔗 Read the full blog: [https://precedefoundation.org/nccn-embraces-precision-medicine/]

30/03/2026

This National Doctors’ Day, we honor the physicians, surgeons, and scientists whose dedication changes and saves lives every day.

At PRECEDE Foundation, we’re proud to work alongside incredible doctors advancing the early detection of pancreatic cancer, bringing hope to patients and families around the world.

Join us in recognizing someone who has made a difference in your life. Make a gift in their honor and help support the groundbreaking research and collaboration driving earlier detection—when treatment is most effective.

20/03/2026

In a recent interview with CancerNetwork, Diane Simeone, MD, discusses how the PRECEDE Consortium is bringing together researchers and clinicians worldwide to improve early detection and transform patient outcomes.

With pancreatic cancer’s five-year survival rate at about 13%, efforts like PRECEDE aim to shift diagnosis to earlier stages, when survival can improve dramatically, and ultimately raise survival to 50% by 2035.

Learn how this global collaboration is working to reshape the future of pancreatic cancer care.

🔗 Read the blog: [https://precedefoundation.org/dr-diane-simeone-discusses-the-importance-of-collaboration-in-cancer-care-in-recent-cancernetwork-interview/]

08/03/2026

Happy International Women’s Day! Today we’re proud to celebrate the extraordinary women leading the change in pancreatic cancer research and early detection. From our female founder, Dr. Diane Simeone, to the many brilliant women doctors across the PRECEDE network, these leaders are transforming the future of pancreatic cancer and how we detect it — giving patients hope through innovation and collaboration.

🔗 Read the full blog: [https://precedefoundation.org/international-womens-day-celebrating-the-women-of-precede-and-beyond/]

27/02/2026

Earlier this month, Jewish Insider featured PRECEDE and president Jamie Brickell in an article highlighting the risk of pancreatic cancer in Ashkenazi Jews.

Pancreatic cancer is often silent in its early stages, but understanding genetic risk can change outcomes.

🔗 Learn more: [https://precedefoundation.org/pancreatic-cancer-risk-in-ashkenazi-jews-what-you-should-know/]

23/02/2026

February is National Cancer Prevention Month, a reminder that small, informed choices today can protect your health tomorrow. From daily habits to early screenings, prevention starts with awareness.💜

🔗 Read the full blog: [https://precedefoundation.org/national-cancer-prevention-month-early-detection-saves-lives/]

04/02/2026

This World Cancer Day, there is real progress to celebrate and urgent work still to do.

New 2026 cancer statistics show that 70% of people now survive at least five years after a cancer diagnosis. But pancreatic cancer remains one of the deadliest, with survival rates still near 13%.

In our latest blog, we break down what today’s cancer statistics mean for tomorrow and why early detection is essential to changing the future of pancreatic cancer.

🔗 Learn more: [https://precedefoundation.org/world-cancer-day-2026-what-todays-statistics-mean-for-tomorrow/]

Address

Website

https://precedefoundation.org/

Alerts

Be the first to know and let us send you an email when Precede Foundation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your organization to be the top-listed Non Profit Organization?

Country:

City: